BlackRock’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $655K | Sell |
|
|||||
|
2025
Q1 | $3.13M | Sell |
|
|||||
|
2024
Q4 | $2.48M | Buy |
|
|||||
|
2024
Q3 | $3.64M | Buy |
|
|||||
|
2024
Q2 | $13.9M | Buy |
|
|||||
|
2024
Q1 | $13.4M | Buy |
|
|||||
|
2023
Q4 | $8.59M | Sell |
|
|||||
|
2023
Q3 | $10.4M | Buy |
|
|||||
|
2023
Q2 | $12.6M | Buy |
|
|||||
|
2023
Q1 | $5.17M | Buy |
|
|||||
|
2022
Q4 | $5.14M | Buy |
|
|||||
|
2022
Q3 | $1.87M | Buy |
|
|||||
|
2022
Q2 | $1.11M | Buy |
|
|||||
|
2022
Q1 | $1.18M | Buy |
|
|||||
|
2021
Q4 | $1.37M | Buy |
|
|||||
|
2021
Q3 | $1.94M | Sell |
|
|||||
|
2021
Q2 | $1.76M | Buy |
|
|||||
|
2021
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q4 | $1.56M | Buy |
|
|||||
|
2020
Q3 | $1.92M | Sell |
|
|||||
|
2020
Q2 | $3.17M | Buy |
|
|||||
|
2020
Q1 | $390K | Buy |
|
|||||
|
2019
Q4 | $257K | Buy |
|
|||||
|
2019
Q3 | $110K | Buy |
|
|||||
|
2019
Q2 | $117K | Buy |
|
|||||
|
2019
Q1 | $228K | Buy |
|
|||||
|
2018
Q4 | $183K | Buy |
|
|||||
|
2018
Q3 | $348K | Buy |
|
|||||
|
2018
Q2 | $301K | Sell |
|
|||||
|
2018
Q1 | $237K | Sell |
|
|||||
|
2017
Q4 | $437K | Buy |
|
|||||
|
2017
Q3 | $358K | Buy |
|
|||||
|
2017
Q2 | $737K | Sell |
|
|||||
|
2017
Q1 | $1.06M | Buy |
|